Curis Inc reports results for the quarter ended in March - Earnings Summary

Curis

07/05/2024 14:53

* Curis Inc  CRIS.OQ  reported a quarterly adjusted loss of
$2.05​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-2.40.  The mean expectation of five analysts for the quarter
was for a loss of $2.12 per share. Wall Street expected
results to range from $-2.19 to $-2.08 per share.
    * Revenue fell 9.2% to $2.09 million from a year ago;
analysts
expected $2.41 million. 
    * Curis Inc's reported EPS for the quarter was a loss of
$2.05​.
    * The company reported a quarterly loss of $11.88 million.
    * Curis Inc shares had risen by 48.8% this quarter and
gained 26.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Curis Inc is
$23.00 
This summary was machine generated from LSEG data May 7 at 01:52
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -2.12          -2.05          Beat
 Dec. 31 2023      -2.11          -2.03          Beat
 Sep. 30 2023      -2.33          -2.13          Beat
 Jun. 30 2023      -2.36          -2.40          Missed